A list of 20 drugs 'special surveillance', which will be kept under observation peril that is a suspicion that they cause side effects so far unknown. But that does not mean that patients should stop taking. A publication has been the U.S. regulatory agency on medicines, the Food and Drug Administration (FDA), which then put online on its website the quarterly results of their pharmacovigilance system, called the Adverse Event Reporting System (AERS)
0 comments:
Post a Comment